Hallie C Prescott, MD, MSc
Toews Family Legacy Professor of Pulmonary and Critical Care Medicine and Associate Professor of Internal Medicine
Ann Arbor
MI
48109, United States
[email protected]

Available to mentor

Hallie C Prescott, MD, MSc
Associate Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • About

    Dr. Hallie Prescott is an Associate Professor in Pulmonary & Critical Care Medicine at the University of Michigan and a staff physician the Ann Arbor Veterans Affairs Healthcare System. She completed pulmonary/critical care fellowship training in 2014 and currently attends in the Ann Arbor VA outpatient pulmonary clinic and medical intensive care unit, as well as in the Critical Care Medicine Unit at Michigan Medicine. She has a master’s degree in healthcare research, with broad methodological expertise in quantitative, qualitative, and survey research methods. The primary focus of her research program has been on sepsis care and outcomes. She serves as co-chair of the international Surviving Sepsis Campaign Guidelines and leads the Michigan Hospital Medicine Safety Consortium’s Sepsis Initiative. Dr. Prescott’s research contributions have been recognized by awards from American Thoracic Society, American Society of Clinical Innovation, Australia/New Zealand Intensive Care Society, and the Carol A. Kauffman MD Department of Internal Medicine Early Career Endowment Award (2019-2024) from the University of Michigan.

    Qualifications
    • MSc, Healthcare Research
      University of Michigan, Ann Arbor, 2014
    • MD
      The Ohio State University, Columbus, 2007
    • BA
      Middlebury College, Middlebury, 2003
    Center Memberships
    • Center Member
      Center for Integrative Research in Critical Care
    • Center Member
      Institute for Healthcare Policy and Innovation
    Research Overview

    Dr. Hallie Prescott's research focuses on the measurement, management, and outcomes of sepsis.

    Recent Publications See All Publications
    • Journal Article
      Estimating the Population-Level Impact of Empiric Anti-Anaerobic Antibiotics among US Adults Hospitalized with Sepsis.
      Admon AJ, Sjoding MW, Prescott HC, Chanderraj R, Dickson RP. Am J Respir Crit Care Med, 2024 Nov 12; DOI:10.1164/rccm.202405-0955RL
      PMID: 39531631
    • Journal Article
      Development and Validation of the Hospital Medicine Safety Sepsis Initiative Mortality Model.
      Prescott HC, Heath M, Munroe ES, Blamoun J, Bozyk P, Hechtman RK, Horowitz JK, Jayaprakash N, Kocher KE, Younas M, Taylor SP, Posa PJ, McLaughlin E, Flanders SA. Chest, 2024 Nov; 166 (5): 1035 - 1045. DOI:10.1016/j.chest.2024.06.3769
      PMID: 38964673
    • Journal Article
      Frequency of and Risk Factors for Increased Healthcare Utilization After Pediatric Sepsis Hospitalization.
      Carlton EF, Rahman M, Maddux AB, Weiss SL, Prescott HC. Crit Care Med, 2024 Nov 1; 52 (11): 1700 - 1709. DOI:10.1097/CCM.0000000000006406
      PMID: 39297738
    • Journal Article
      Causal inference can lead us to modifiable mechanisms and informative archetypes in sepsis.
      Baillie JK, Angus D, Burnham K, Calandra T, Calfee C, Gutteridge A, Hacohen N, Khatri P, Langley R, Ma'ayan A, Marshall J, Maslove D, Prescott HC, Rowan K, Scicluna BP, Seymour C, Shankar-Hari M, Shapiro N, Joost Wiersinga W, Singer M, Randolph AG. Intensive Care Med, 2024 Dec; 50 (12): 2031 - 2042. DOI:10.1007/s00134-024-07665-4
      PMID: 39432104
    • Journal Article
      Empirical antibiotic therapy for sepsis: save the anaerobic microbiota.
      Kullberg RFJ, Haak BW, Chanderraj R, Prescott HC, Dickson RP, Wiersinga WJ. Lancet Respir Med, 2024 Oct 11; DOI:10.1016/S2213-2600(24)00257-1
      PMID: 39401510
    • Journal Article
      Social Determinants of Health and Risk-Adjusted Sepsis Mortality in the Nationwide Veterans Affairs Healthcare System.
      Seelye S, Cano J, Hogan CK, Prescott HC, Sussman JB. J Gen Intern Med, 2024 Oct 7; DOI:10.1007/s11606-024-09104-y
      PMID: 39375318
    • Journal Article
      Greenhouse Gas Emissions and Costs of Inhaler Devices in the US.
      Tirumalasetty J, Miller SA, Prescott HC, DeTata S, Arroyo AC, Wilkinson AJK, Rabin AS. JAMA, 2024 Sep 24; 332 (12): 1017 - 1019. DOI:10.1001/jama.2024.15331
      PMID: 39207797
    • Journal Article
      Two Weeks Versus One Week of Maximal Patient-Intensivist Continuity for Adult Medical Intensive Care Patients: A Two-Center Target Trial Emulation.
      Admon AJ, Cohen-Mekelburg S, Opatrny M, Lee KT, Law AC, Gershengorn HB, Valley TS, Prescott HC, Wiktor MJ, Neeluru J, Cooke CR, Weissman GE. Crit Care Med, 2024 Sep 1; 52 (9): 1323 - 1332. DOI:10.1097/CCM.0000000000006322
      PMID: 38713002
    Featured News & Stories lungs
    Health Lab
    The environmental toll of inhalers for asthma and COPD
    In a JAMA research letter, Medicare and Medicaid claims data were used to estimate the greenhouse gas emissions of inhalers using propellants versus those that are propellant-free in the United States.